112 related articles for article (PubMed ID: 2647891)
1. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
Fischer AC; Beschorner WE; Hess AD
J Exp Med; 1989 Mar; 169(3):1031-41. PubMed ID: 2647891
[TBL] [Abstract][Full Text] [Related]
2. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
3. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
[TBL] [Abstract][Full Text] [Related]
4. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
[TBL] [Abstract][Full Text] [Related]
5. Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine.
Beschorner WE; Ren H; Phillips J; Pulido HB; Hruban RH; Hess AD
Transplantation; 1991 Oct; 52(4):668-74. PubMed ID: 1926347
[TBL] [Abstract][Full Text] [Related]
6. Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.
Fischer AC; Hess AD
J Exp Med; 1990 Jul; 172(1):85-94. PubMed ID: 2358786
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells.
Bryson JS; Jennings CD; Brandon JA; Perez J; Caywood BE; Kaplan AM
J Leukoc Biol; 2007 Dec; 82(6):1393-400. PubMed ID: 17726153
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Fischer AC; Ruvolo PP; Burt R; Horwitz LR; Bright EC; Hess JM; Beschorner WE; Hess AD
J Immunol; 1995 Apr; 154(8):3713-25. PubMed ID: 7706714
[TBL] [Abstract][Full Text] [Related]
9. X-irradiation of the thymus is not required for the induction of cyclosporine-induced autoimmunity.
Beijleveld LJ; Damoiseaux JG; Wodzig KW; Van Breda Vriesman PJ
Transplantation; 1995 Jun; 59(11):1601-5. PubMed ID: 7778176
[TBL] [Abstract][Full Text] [Related]
10. Syngeneic graft-versus-host disease: failure of autoregulation in self/non-self discrimination.
Fischer AC; Beschorner WE; Hess AD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):493-500. PubMed ID: 3291287
[No Abstract] [Full Text] [Related]
11. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats.
Bos GM; Majoor GD; van Breda Vriesman PJ
Clin Exp Immunol; 1988 Dec; 74(3):443-8. PubMed ID: 2976623
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.
Glazier A; Tutschka PJ; Farmer ER; Santos GW
J Exp Med; 1983 Jul; 158(1):1-8. PubMed ID: 6345713
[TBL] [Abstract][Full Text] [Related]
13. T-cell maturation and clonal deletion in cyclosporine-induced autoimmunity.
Prud'homme GJ; Sanders R; Parfrey NA; Ste-Croix H
J Autoimmun; 1991 Apr; 4(2):357-68. PubMed ID: 1652970
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin-induced autoimmunity: a role for marrow-derived cells presenting self antigens in the thymus.
Babcock SK; Georgiu H; Kotzin B; Bellgau D
Transplant Proc; 1989 Feb; 21(1 Pt 1):220-1. PubMed ID: 2650108
[No Abstract] [Full Text] [Related]
15. Loss of medullary dendritic cells in the thymus after cyclosporine and irradiation.
Beschorner WE; Armas OA
Cell Immunol; 1991 Feb; 132(2):505-14. PubMed ID: 1988165
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.
Sorokin R; Kimura H; Schroder K; Wilson DH; Wilson DB
J Exp Med; 1986 Nov; 164(5):1615-25. PubMed ID: 3490534
[TBL] [Abstract][Full Text] [Related]
17. Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
Hess AD; Horwitz L; Beschorner WE; Santos GW
J Exp Med; 1985 Apr; 161(4):718-30. PubMed ID: 2580038
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
19. Induction of murine syngeneic graft-versus-host disease by cells of recipient origin.
Brandon JA; Jennings CD; Perez J; Caywood B; Alapat D; Kaplan AM; Bryson JS
Transplantation; 2007 Jun; 83(12):1620-7. PubMed ID: 17589346
[TBL] [Abstract][Full Text] [Related]
20. On the localization of effector cells in cyclosporin-induced autoimmunity.
Wodzig KW; Majoor GD; van Breda Vriesman PJ
Autoimmunity; 1991; 10(4):275-83. PubMed ID: 1772963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
